CD4 and hepatocellular carcinoma: Altogether, these data delineate that NETs break CD4+ T‐cell homeostasis by metabolic reprogramming and tilt the balance toward Tregs, thereby facilitating the dysregulated immune surveillance in the pathogenesis of NASH–HCC (Figure 3).